Meagan Cage is a pharmacist who is specialized in Pharmacotherapy in Frisco, Texas. Patients can reach her at 1595 Idlewild Dr, Frisco or contact her on 972-757-4191. Active license number of Meagan Cage is 69825 for Pharmacotherapy in Texas. Meagan Cage is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Meagan Cage speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Meagan Cage
Specialization:
Pharmacotherapy
Gender:
Female
Location:
1595 Idlewild Dr, Frisco, Texas, 75036-7778
Phone:
972-757-4191
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Meagan Cage are as mentioned below.
NPI Number:
1689326902
NPI Enumeration Date:
19 Jan, 2022
NPI Last Update On:
19 Jan, 2022
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Meagan Cage are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
69825
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1595 Idlewild Dr, Frisco, Texas
Zip:
75036-7778
Phone Number:
--
Fax Number:
--
Patients can reach Meagan Cage at 1595 Idlewild Dr, Frisco, Texas or can call on phone at 972-757-4191.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.